{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:42:09Z","timestamp":1779882129124,"version":"3.53.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pain control in infants is an important clinical concern, with potential long-term adverse neurodevelopmental effects. Intravenous morphine is routinely administered for postoperative pain management; however, its dose\u2013concentration\u2013response relationship in neonates and infants has not been well characterized. Although the current literature provides dosing guidelines for the average infant, it fails to control for the large unexplained variability in morphine clearance and response in individual patients. Bayesian estimation can be used to control for some of this variability. The authors aimed to evaluate morphine pharmacokinetics (PKs) and exposure in critically ill neonates and infants receiving standard-of-care morphine therapy and compare a population-based approach to the model-informed Bayesian techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The PKs and exposure of morphine and its active metabolites were evaluated in a prospective opportunistic PK study using 221 discarded blood samples from 57 critically ill neonates and infants in the neonatal intensive care unit. Thereafter, a population-based PK model was compared with a Bayesian adaptive control strategy to predict an individual's PK profile and morphine exposure over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among the critically ill neonates and infants, morphine clearance showed substantial variability with a 40-fold range (ie, 2.2 to 87.1, mean 23.7 L\/h\/70 kg). Compared with the observed morphine concentrations, the population-model based predictions had an R<jats:sup>2<\/jats:sup> of 0.13, whereas the model-based Bayesian predictions had an R<jats:sup>2<\/jats:sup> of 0.61.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Model-informed Bayesian estimation is a better predictor of morphine exposure than PK models alone in critically ill neonates and infants. A large variability was also identified in morphine clearance. A further study is warranted to elucidate the predictive covariates and precision dosing strategies that use morphine concentration and pain scores as feedbacks.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000763","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T18:38:33Z","timestamp":1589913513000},"page":"778-786","source":"Crossref","is-referenced-by-count":7,"title":["Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and Infants"],"prefix":"10.1097","volume":"42","author":[{"given":"Joshua C.","family":"Euteneuer","sequence":"first","affiliation":[{"name":"Division of Neonatology, Cincinnati Children's Hospital Medical Center, Perinatal Institute, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Pathology, Mass Spectrometry Laboratory, Cincinnati Children's Hospital Medical Center; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D. R.","family":"Setchell","sequence":"additional","affiliation":[{"name":"Division of Pathology, Mass Spectrometry Laboratory, Cincinnati Children's Hospital Medical Center; and"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Muglia","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Cincinnati Children's Hospital Medical Center, Perinatal Institute, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Vinks","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am J Perinatol"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/pan.12361","article-title":"Why is there no morphine concentration-response curve for acute pain?","volume":"24","author":"Anderson","year":"2014","journal-title":"Paediatr Anaesth."},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00003088-200948060-00003","article-title":"Morphine glucuronidation in preterm neonates, infants and children younger than 3 years","volume":"48","author":"Knibbe","year":"2009","journal-title":"Clin Pharmacokinet."},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/aeh042","article-title":"Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children","volume":"92","author":"Bouwmeester","year":"2004","journal-title":"Br J Anaesth."},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40262-012-0006-9","article-title":"Prediction of morphine clearance in the paediatric population: how accurate are the available pharmacokinetic models?","volume":"51","author":"Krekels","year":"2012","journal-title":"Clin Pharmacokinet."},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40262-014-0135-4","article-title":"Evidence-based morphine dosing for postoperative neonates and infants","volume":"53","author":"Krekels","year":"2014","journal-title":"Clin Pharmacokinet."},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/bja\/aen248","article-title":"Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial","volume":"101","author":"Anand","year":"2008","journal-title":"Br J Anaesth."},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1460-9592.2011.03782.x","article-title":"Prediction of morphine dose in humans","volume":"22","author":"Holford","year":"2012","journal-title":"Paediatr Anaesth."},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40261-013-0097-6","article-title":"Developmental changes in morphine clearance across the entire paediatric age range are best described by a bodyweight-dependent exponent model","volume":"33","author":"Wang","year":"2013","journal-title":"Clin Drug Investig."},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejps.2016.06.026","article-title":"Pharmacokinetic models of morphine and its metabolites in neonates: systematic comparisons of models from the literature, and development of a new meta-model","volume":"92","author":"Knosgaard","year":"2016","journal-title":"Eur J Pharm Sci."},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/j.1532-2149.2011.00056.x","article-title":"Protocolized post-operative pain management in infants; do we stick to it?","volume":"16","author":"Ceelie","year":"2012","journal-title":"Eur J Pain."},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1371\/journal.pmed.0050129","article-title":"How well do clinical pain assessment tools reflect pain in infants?","volume":"5","author":"Slater","year":"2008","journal-title":"PLoS Med."},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/03602538409015063","article-title":"The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods","volume":"15","author":"Sheiner","year":"1984","journal-title":"Drug Metab Rev."},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00007691-200006000-00018","article-title":"Achieving target goals most precisely using nonparametric compartmental models and \u201cmultiple model\u201d design of dosage regimens","volume":"22","author":"Jelliffe","year":"2000","journal-title":"Ther Drug Monit."},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/0091270009356572","article-title":"Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician","volume":"50","author":"Neely","year":"2010","journal-title":"J Clin Pharmacol."},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40262-015-0291-1","article-title":"Pharmacokinetic studies in neonates: the utility of an opportunistic sampling design","volume":"54","author":"Leroux","year":"2015","journal-title":"Clin Pharmacokinet."},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/1574884709666140520153308","article-title":"Pharmacokinetic studies in infants using minimal-risk study designs","volume":"9","author":"Autmizguine","year":"2014","journal-title":"Curr Clin Pharmacol."},{"key":"R18-20230928","first-page":"59","article-title":"The development of a tool to assess neonatal pain","volume":"12","author":"Lawrence","year":"1993","journal-title":"Neonatal Network."},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-3476(85)80205-5","article-title":"Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety","volume":"107","author":"Koren","year":"1985","journal-title":"J Pediatr."},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cpt.1684","article-title":"Electronic health record-embedded decision support platform for morphine precision dosing in neonates","volume":"107","author":"Vinks","year":"2020","journal-title":"Clin Pharmacol Ther."},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/psp4.12404","article-title":"NONMEM tutorial part I: description of commands and options, with simple examples of population analysis","volume":"8","author":"Bauer","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/psp4.12422","article-title":"NONMEM tutorial part II: estimation methods and advanced examples","volume":"8","author":"Bauer","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm."},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/aeg121","article-title":"Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants","volume":"90","author":"Bouwmeester","year":"2003","journal-title":"Br J Anaesth."},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5414\/CP202561","article-title":"Neonatal pain management: still in search for the Holy Grail","volume":"54","author":"Allegaert","year":"2016","journal-title":"Int J Clin Pharmacol Ther."},{"key":"R29-20230928","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1113\/EP085134","article-title":"What do we really know about newborn infant pain?","volume":"100","author":"Fitzgerald","year":"2015","journal-title":"Exp Physiol."},{"key":"R30-20230928","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/070674371506000404","article-title":"Long-term consequences of neonatal injury","volume":"60","author":"Beggs","year":"2015","journal-title":"Can J Psychiatry."},{"key":"R31-20230928","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/ejn.12414","article-title":"The consequences of pain in early life: injury-induced plasticity in developing pain pathways","volume":"39","author":"Schwaller","year":"2014","journal-title":"Eur J Neurosci."},{"key":"R32-20230928","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1213\/00000539-199310000-00007","article-title":"Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery","volume":"77","author":"Lynn","year":"1993","journal-title":"Anesth Analg."},{"key":"R33-20230928","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1067\/mcp.2000.108947","article-title":"Morphine clearance and effects in newborn infants in relation to gestational age","volume":"68","author":"Saarenmaa","year":"2000","journal-title":"Clin Pharmacol Ther."},{"key":"R34-20230928","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1002\/psp4.17","article-title":"Development of a pediatric physiologically based pharmacokinetic model for sirolimus: applying principles of growth and maturation in neonates and infants","volume":"4","author":"Emoto","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"R35-20230928","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/FTD.0000000000000130","article-title":"Age-dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1","volume":"37","author":"Emoto","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R36-20230928","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.1315","article-title":"Suggestions for model-informed precision dosing to optimize neonatal drug therapy","volume":"59","author":"Euteneuer","year":"2019","journal-title":"J Clin Pharmacol."},{"key":"R37-20230928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics."},{"key":"R38-20230928","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26470","article-title":"Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies","volume":"64","author":"Mizuno","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"R39-20230928","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.ejps.2017.05.037","article-title":"Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies","volume":"109S","author":"Mizuno","year":"2017","journal-title":"Eur J Pharm Sci."},{"key":"R40-20230928","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/ac103150a","article-title":"Direct analysis of biological tissue by paper spray mass spectrometry","volume":"83","author":"Wang","year":"2011","journal-title":"Anal Chem."},{"key":"R41-20230928","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s13361-011-0177-x","article-title":"Quantitative analysis of therapeutic drugs in dried blood spot samples by paper spray mass spectrometry: an avenue to therapeutic drug monitoring","volume":"22","author":"Manicke","year":"2011","journal-title":"J Am Soc Mass Spectrom."},{"key":"R43-20230928","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1373\/clinchem.2016.263715","article-title":"Stable-isotope dilution HPLC-electrospray ionization tandem mass spectrometry method for quantifying hydroxyurea in dried blood samples","volume":"62","author":"Marahatta","year":"2016","journal-title":"Clin Chem."},{"key":"R44-20230928","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cpt.1249","article-title":"Influence of OCT1 ontogeny and genetic variation on morphine disposition in critically ill neonates: lessons from PBPK modeling and clinical study","volume":"105","author":"Hahn","year":"2019","journal-title":"Clin Pharmacol Ther."},{"key":"R45-20230928","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/cpt.1607","article-title":"Next challenge from the variance in individual physiologically-based pharmacokinetic model-predicted to observed morphine concentration in critically ill neonates","volume":"107","author":"Emoto","year":"2019","journal-title":"Clin Pharmacol Ther."},{"key":"R46-20230928","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jcph.1592","article-title":"Influence of MRP3 genetics and hepatic expression ontogeny for morphine disposition in neonatal and pediatric patients","volume":"8","author":"Hahn","year":"2020","journal-title":"J Clin Pharmacol."},{"key":"R47-20230928","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5055\/jom.2012.0119","article-title":"Morphine clearance in children: does race or genetics matter?","volume":"8","author":"Sadhasivam","year":"2012","journal-title":"J Opioid Manag."},{"key":"R48-20230928","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","article-title":"Morphine-3-glucuronide\u2014a potent antagonist of morphine analgesia","volume":"47","author":"Smith","year":"1990","journal-title":"Life Sci."},{"key":"R49-20230928","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/00912700222011508","article-title":"Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers","volume":"42","author":"Murthy","year":"2002","journal-title":"J Clin Pharmacol."},{"key":"R50-20230928","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.1992.tb04121.x","article-title":"The analgesic activity of morphine-6-glucuronide","volume":"34","author":"Osborne","year":"1992","journal-title":"Br J Clin Pharmacol."},{"key":"R51-20230928","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(91)90199-Z","article-title":"Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide","volume":"193","author":"Gong","year":"1991","journal-title":"Eur J Pharmacol."},{"key":"R52-20230928","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejpain.2007.07.009","article-title":"Morphine-6-glucuronide (M6G) for postoperative pain relief","volume":"12","author":"Dahan","year":"2008","journal-title":"Eur J Pain."},{"key":"R53-20230928","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1542\/peds.2011-2607","article-title":"Race and unequal burden of perioperative pain and opioid related adverse effects in children","volume":"129","author":"Sadhasivam","year":"2012","journal-title":"Pediatrics."},{"key":"R55-20230928","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.clp.2013.05.001","article-title":"Assessment of pain in the neonate","volume":"40","author":"Maxwell","year":"2013","journal-title":"Clin Perinatol."},{"key":"R56-20230928","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1523\/JNEUROSCI.0348-06.2006","article-title":"Cortical pain responses in human infants","volume":"26","author":"Slater","year":"2006","journal-title":"J Neurosci."},{"key":"R57-20230928","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/apa.12848","article-title":"Functional magnetic resonance imaging can be used to explore tactile and nociceptive processing in the infant brain","volume":"104","author":"Williams","year":"2015","journal-title":"Acta Paediatr."},{"key":"R58-20230928","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejpain.2009.05.005","article-title":"Evoked potentials generated by noxious stimulation in the human infant brain","volume":"14","author":"Slater","year":"2010","journal-title":"Eur J Pain."},{"key":"R59-20230928","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.j.pain.0000460302.56325.0c","article-title":"Cortical activity evoked by inoculation needle prick in infants up to one-year old","volume":"156","author":"Verriotis","year":"2015","journal-title":"Pain."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:06:37Z","timestamp":1695863197000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000763","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}